Lafayette Energy Corp. LEC 深 沪
等待开盘 11-18 09:30:00 美东时间
0.00
0.000
NaN.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.00
- 总市值 0
- 52周最高 0.00
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.00
- 委 比 0.00%
- 总股本 1075.37万
- 历史最高 0.00
- 量 比 0
- 振 幅 NaN.00%
- 历史最低 0.00
- 每 手 1
- 风险率
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多生产经营｜江南造船交付一艘99000立方米VLEC
10月27日 江南造船为西南海运建造的 99000立方米超大型乙烷运输船（VLEC 2.0） 系列船第二艘（H2711船）签字交付 该船于8月16日与该系列首制...
10-28 19:22
RICHMOND MUTUAL BANCORPORATION, INC. ANNOUNCES 2025 THIRD QUARTER FINANCIAL RESULTS
RICHMOND, Ind., Oct. 23, 2025 /PRNewswire/ -- Richmond Mutual Bancorporation, Inc., a Maryland corporation (the "Company") (NASDAQ: RMBI), parent company of First Bank Richmond (the "Bank"),...
10-24 04:30
LaFayette Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering
LaFayette Acquisition Corp. announced the pricing of its initial public offering of 10 million units at $10.00 per unit, expected to begin trading on October 24, 2025, on the Nasdaq Global Market under the symbol "LAFAU." The company, led by Christophe Charlier, is a special purpose acquisition company targeting a merger or business combination. Each unit consists of one ordinary share and one right to receive one-tenth of a share upon completing...
10-23 20:50
生产经营｜江南造船48500立方米中型乙烷乙烯运输船系列首制船开工
10月16日，江南造船为Navigator Gas公司建造的48500立方米中型乙烷乙烯运输船（MEC）首制船H2854在制造三部切割车间顺利开工。 ...
10-21 17:28
航运市场分析与租金价格走势
（来源：租赁小哥） 在租赁公司转型期，船舶资产凭借其稳定性、流通性等优势，成为租赁公司的压舱石。但受航运周期影响，布局船舶资产仍面临挑战。如何研判航运周期，实现...
10-21 16:11
AbbVie's Rinvoq beats Humira in head-to-head rheumatoid arthritis trial
AbbVie (NYSE:ABBV) said that a phase 3b/4 head-to-head trial pitting Rinvoq (upadacitinib) against Humira (adalimumab) in rheumatoid arthritis demonstrated the former's superiority over the latter. Re...
10-21 01:25
AbbVie Announced Topline Results From The Phase 3b/4 Head-To-Head Select-Switch Study Evaluating The Efficacy And Safety Of Upadacitinib; Says Upadacitinib Outperforms Adalimumab In Study, Achieves Key Efficacy Endpoints With No New Safety Risks
Upadacitinib demonstrated superiority versus adalimumab for primary endpoint of achieving low disease activity (DAS28-CRP≤3.2) and ranked secondary endpoint of remission (DAS28-CRP<2.6) at week
10-20 20:10
Ola Electric Updates Registrar’s Contact Information
An announcement from Ola Electric Mobility Limited ( ($IN:OLAELEC) ) is now ava...
10-08 03:34
Ola Electric Strengthens Financial Base with Strategic OCRPS Allotment
Ola Electric Mobility Limited ( ($IN:OLAELEC) ) has issued an update. Ola Elect...
10-08 03:33
